Female urinary incontinence: effective treatment strategies

References

• Haylen BT, de Ridder D, Freeman RM et al. An International Urogynaecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 2010;21:5–26
   PubMed Web of Science ®Google Scholar
• Thom D. Variation in estimates of urinary incontinence prevalence in the community: effects of differences in definition, population characteristics, and study type. J Am Geriatr Soc 1998;46:473–80
   PubMed Web of Science ®Google Scholar
• Herzog AR, Fultz NH. Prevalence and incidence of urinary incontinence in community-dwelling populations. J Am Geriatr Soc 1990;38:273–81
   PubMed Web of Science ®Google Scholar
• Hannestad YS, Rortveit G, Sandvik H, Hunskar S. A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. J Clin Epidemiol 2000;53:1150–7
   PubMed Web of Science ®Google Scholar
• Bourcier AP, Juras JC. Nonsurgical therapy for stress incontinence. Urol Clin North Am 1995;22:613–27
   PubMed Web of Science ®Google Scholar
• Arruda RM, Castro RA, Sousa GC, Sartori MG, Baracat EC, Girão MJ. Prospective randomized comparison of oxybutynin, functional electrostimulation, and pelvic floor training for treatment of detrusor overactivity in women. Int Urogynecol J 2008;19:1055–61
   PubMed Web of Science ®Google Scholar
• Castro RA, Arruda RM, Zanetti MRD, Santos PD, Sartori MGF, Girão MJBC. Single-blind, randomized, controlled trial of pelvic floor muscle training, electrical stimulation, vaginal cones, and no active treatment in the management of stress urinary incontinence. Clinics 2008;63:465–72
   PubMed Web of Science ®Google Scholar
• Cardozo L. Systematic review of overactive bladder therapy in females. Can Urol Assoc J 2011;5(Suppl 2):S139–42
   Google Scholar
• Moore K, Dumoulin C, Bradley C, et al. Adult conservative management. In Abrams P, Cardozo L, Khoury S, Wein A, eds. Incontinence, 5th edn. Paris: Health Publication Ltd, 2013: 1101–228
   Google Scholar
• Wyman J. Bladder training for overactive bladder. In Bo K, Berghmans B, Morkved S, Van Kampen M, eds. Evidence-based Physical Therapy for the Pelvic Floor. New York: Elsevier, 2007: 208–18
   Google Scholar
• Ouslander JG. Management of overactive bladder. N Engl J Med 2004;350:786–99
   PubMed Web of Science ®Google Scholar
• Cho SY, Lee SL, Kim IS, Koo DH, Kim HJ, Oh SJ. Short-term effects of systematized behavioral modification program for nocturia: a prospective study. Neurourol Urodyn 2012;31:64–8
   PubMed Web of Science ®Google Scholar
• Soda T, Masui K, Okuno H, Terai A, Ogawa O, Yoshimura K. Efficacy of nondrug lifestyle measures for the treatment of nocturia. J Urol 2010;184:1000–4
   PubMed Web of Science ®Google Scholar
• Dalosso HM, McGrother CW, Matthews RJ, Donaldson MMK. The association of diet and other lifestyle factors with overactive bladder and stress incontinence: a longitudinal study in women. BJU 2003;92:69–77
   PubMed Web of Science ®Google Scholar
• Cartwright R, Srikrishna S, Cardozo L, et al. Does Diet Coke cause overactive bladder? A 4-way crossover trial, investigating the effect of carbonated soft drinks on overactive bladder symptoms in normal volunteers [poster]. Presented at 2007 Annual Meeting of the International Continence Society, Rotterdam
   Google Scholar
• Wallace SA, Roe B, Williams K, et al. Bladder training for urinary incontinence in adults. Cochrane Database of Systematic Reviews 2004. Cochrane Library, Issue 1. Art. No.: CD001308
   Google Scholar
• Dumoulin C, Hay-Smith J, Mac Habée-Séguin G. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database of Systematic Reviews 2014. Cochrane Library, Issue 4, Art. No. CD005654
   Google Scholar
• Ayeleke RO, Hay-Smith EJ, Omar MI. Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women. Cochrane Database of Systematic Reviews 2013. Cochrane Library, Issue 4, Art. No. CD010551
   Google Scholar
• Bo K. Pelvic floor muscle training in treatment of female stress urinary incontinence, pelvic organ prolapse and sexual dysfunction. World J Urol 2012;30:437–43
   PubMed Web of Science ®Google Scholar
• Holroyd-Leduc JM, Straus SE. Management of urinary incontinence in women: scientific review. JAMA 2004;291:986–95
   PubMed Web of Science ®Google Scholar
• Hay-Smith EJC, Herderschee R, Dumoulin C, Herbison GP. Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women. Cochrane Database of Systematic Reviews 2011. Cochrane Library, Issue 4, Art. No. CD009508
   Google Scholar
• Lagro-Janssen TL, Debruyne FM, Smits AJ, van Weel C. Controlled trial of pelvic floor exercises in the treatment of urinary stress incontinence in general practice. Br J Gen Pract 1991;41:445–9
   PubMed Web of Science ®Google Scholar
• Wilson PD, Barker G, Barnard RJ, Siddle NC. Steroid hormone receptors in the female lower urinary tract. Urol Int 1994; 39:5–8
   Web of Science ®Google Scholar
• Sartori MG, Feldner PC, Jarmy-Di Bella ZI, et al. Sexual steroids in urogynecology. Climacteric 2011;14:5–14
   PubMed Web of Science ®Google Scholar
• Moehrer B, Hextall A, Jackson S. Oestrogens for urinary incontinence in women. Cochrane Database of Systematic Reviews 2003. Cochrane Library, Issue 2. Art. No.CD001405
   Google Scholar
• Grady D, Brown JS, Vittinghoff E, Applegate W, Varner E, Snyder T; HERS Research Group. Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study. Obstet Gynecol 2001;97:116–20
   PubMed Web of Science ®Google Scholar
• Hendrix SL, Cochrane BB, Nygaard IE, et al. Effects of estrogen with and without progestin on urinary incontinence. JAMA 2005;293:935–48
   PubMed Web of Science ®Google Scholar
• Thor KB, Katofiasc MA. Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetised female cat. Pharmacol Exp Ther 1995;74:1014–24
   Google Scholar
• Millard R, Moore K, Yalcin I, Bump R. Duloxetine vs. placebo in the treatment of stress urinary incontinence: a global Phase III study. Neurourol Urodynam 2003;22:482–3
   Google Scholar
• Mariappan P, Ballantyne Z, N’Dow JM, Alhasso AA. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults. Cochrane Database of Systematic Reviews 2005. Cochrane Library, Issue 3, Art. No. CD004742
   Google Scholar
• Chapple CR. The contemporary pharmacological management of overactive bladder. BJOG 2006;113(Suppl 2):19–28
   Web of Science ®Google Scholar
• Yamaguchi O, Nishizawa O, Takeda M, et al. Clinical guidelines for overactive bladder. Int J Urol 2009;16:126–42
   PubMed Web of Science ®Google Scholar
• Nabi G, Cody JD, Ellis G, et al. Anticholinergic drugs versus placebo for overactive bladder syndrome in adults. Cochrane Database of Systematic Reviews 2006. Cochrane Library, Issue 4, Art. No.: CD003781
   Google Scholar
• Abrams P, Cardozo L, Khoury S, Wein A. Incontinence, 5th edn. Paris: Health Publication Ltd, 2013
   Google Scholar
• Chapple CR, Khullar V, Gabriel Z, et al. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol 2008;54:543–62
   PubMed Web of Science ®Google Scholar
• Burgio KL, Locher JL, Goode PS. Combined behavioral and drug therapy of urge incontinence in older women. J Am Geriatr Soc 2000;48:370–4
   PubMed Web of Science ®Google Scholar
• Rai BP, Cody JD, Alhasso A, et al. Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults. Cochrane Database of Systematic Reviews 2012. Cochrane Library, Issue 12. Art. No.: CD003193
   Google Scholar
• Wagg A, Compion G, Fahey A, Siddiqui E. Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experience. BJU Int 2012;110:1767–74
   PubMed Web of Science ®Google Scholar
• Marinkovic SP, Rovner ES, Moldwin RM, et al. The management of overactive bladder syndrome. BMJ 2012;344:e2365
   PubMed Web of Science ®Google Scholar
• Madhuvrata P, Cody JD, Ellis G, et al. Which anticholinergic drug for overactive bladder symptoms in adults. Cochrane Database of Systematic Reviews 2012. Cochrane Library, Issue 1. Art. No.: CD005429
   Google Scholar
• Khullar V, Amarenco G, Angulo JC, et al. Efficacy and tolerability of mirabegron, a b3 adrenoceptor agonist, in patients with overactive bladder: results from a randomised European– Australian Phase III trial. Eur Urol 2013;63:283–95
   PubMed Web of Science ®Google Scholar
• Robinson D, Cardozo L. Urinary incontinence in the young woman: treatment plans and options available. Women’s Health 2014;10:201–17
   Google Scholar
• Tincello DG, Rashid T, Revicky V. Emerging treatments for overactive bladder: clinical potential of botulinum toxins. Res Rep Urol 2014;6:51–7
   Google Scholar
• Duthie JB, Vincent M, Herbison GP, et al. Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database of Systematic Reviews 2011. Cochrane Library, Issue 12. Art. No.: CD005493
   Google Scholar
• Kennelly M, Dmochowski R, Ethans K, et al. Long-term efficacy and safety of onabotulinum toxin A in patients with urinary incontinence due to neurogenic detrusor overactivity: an interim analysis. Urology 2013;81:491–7
   PubMed Web of Science ®Google Scholar
• Gousse AE, Kanagarajah P, Ayyathurai R, et al. Repeat intradetrusor injections of onabotulinum toxin a for a refractory idiopathic overactive bladder patients: a single-center experience. Female Pelvic Med Reconstr Surg 2011;17:253–7
   PubMed Web of Science ®Google Scholar
• Cohen BL, Barboglio P, Rodriguez D, et al. Preliminary results of a dose-finding study for botulinum toxin-A in patients with idiopathic overactive bladder: 100 versus 150 units. Neurourol Urodyn 2009;28:205–8
   PubMed Web of Science ®Google Scholar
• Leng WW, Chancellor MB. How sacral nerve stimulation neuromodulation works. Urol Clin North Am 2005;32:11–18
   PubMed Web of Science ®Google Scholar
• Laviana A, Jellison F, Kim JH. Sacral neuromodulation for refractory overactive bladder, interstitial cystitis, and painful bladder syndrome. Neurosurg Clin N Am 2014;25:33–46
   PubMed Web of Science ®Google Scholar
• Ward K, Hilton P. Prospective multicentre randomised trial of tension-free vaginal tape and colposuspension as primary treatment for stress incontinence. BMJ 2002;325:367–73
   PubMed Web of Science ®Google Scholar
• Ward KL, Hilton P; UK and Ireland TVT Trial Group. Tension-free vaginal tape versus colposuspension for primary urodynamic stress incontinence: 5-year follow-up. BJOG 2008;115:226–33
   PubMed Web of Science ®Google Scholar
• Ogah J, Cody JD, Rogerson L. Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women. Cochrane Database of Systematic Reviews 2009. Cochrane Library, Issue 4. Art. No.: CD006375
   Google Scholar
• http://www.augs.org/d/do/2535 [accessed 25 Jun 14]
   Google Scholar
• Serati M, Salvatore S, Uccella S, et al. Surgical treatment for female stress urinary incontinence: what is the gold-standard procedure? Int Urogynecol J 2009;20:619–21
   PubMed Web of Science ®Google Scholar
• Novara G, Artibani W, Barber MD, et al. Updated systematic review and meta-analysis of the comparative data on colposuspensions, pubovaginal slings, and midurethral tapes in the surgical treatment of female stress urinary incontinence. Eur Urol 2010;58:218–38
   PubMed Web of Science ®Google Scholar
• Richter HE, Albo ME, Zyczynski HM, et al.; Urinary Incontinence Treatment Network. Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med 2010;362:2066–76
   PubMed Web of Science ®Google Scholar
• Ulmsten U, Henriksson L, Johnson P, et al. An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence. Int Urogynecol J 1996;7:81–6
   PubMedGoogle Scholar
• Ulmsten U, Falconer C, Johnson P, et al. A multicenter study of Tension-Free Vaginal Tape (TVT) for surgical treatment of stress urinary incontinence. Int Urogynecol J 1998;9:210–13
   PubMedGoogle Scholar
• Nilsson CG, Palva K, Rezapour M, Falconer C. Eleven years prospective follow-up of the tension-free vaginal tape procedure for treatment of stress urinary incontinence. Int Urogynecol J 2008;19:1043–7
   PubMed Web of Science ®Google Scholar
• Nilsson CG, Palva K, Aarnio R, et al. Seventeen years’ follow up of the tension free vaginal tape procedure for female stress urinary incontinence. Int Urogynecol J 2013;24:1265–9
   PubMed Web of Science ®Google Scholar
• Rezapour M, Ulmsten U. Tension-free vaginal tape (TVT) in women with recurrent stress urinary incontinence- a long-term follow-up. Int Urogynecol J 2001;12(Suppl 2):S9–11
   PubMed Web of Science ®Google Scholar
• Rezapour M, Ulmsten U. Tension-Free vaginal tape (TVT) in women with mixed urinary incontinence – a long-term follow-up. Int Urogynecol J 2001;12(Suppl 2):S15–18
   Google Scholar
• Rezapour M, Falconer C, Ulmsten U. Tension-Free vaginal tape (TVT) in stress incontinent women with intrinsic sphincter deficiency (ISD): a long-term follow-up. Int Urogynecol J 2001; 12(Suppl 2):S12–14
   PubMed Web of Science ®Google Scholar
• Daneshgari F, Kong W, Swartz M. Complications of mid urethral slings: important outcomes for future clinical trials. J Urol 2008;180:1890–7
   PubMed Web of Science ®Google Scholar
• Delorme E. La bandelette trans-obturatrice: um procédé mini-invasif pour traiter l'incontinence urinaire d'effort de la femme. Prog Urol 2001;11:1306–13
   PubMed Web of Science ®Google Scholar
• DeLancey JOL. Structural support of the urethra as it relates to stress urinary incontinence: the hammock hypothesis. Am J Obstet Gynecol 1994;170:1713–23
   PubMed Web of Science ®Google Scholar
• de Leval J. Novel surgical technique for the treatment of female stress urinary incontinence: transobturator vaginal tape inside-out. Eur Urol 2003;44:724–30
   PubMed Web of Science ®Google Scholar
• deTayrac R, Deffieux X, Droupy S, Chauveaud-Lambling A, Calvanèse-Benamour L, Fernandez H. A prospective randomized trial comparing tension-free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence. Am J Obstet Gynecol 2004;190:602–8
   PubMed Web of Science ®Google Scholar
• Roumeguère T, Quackels T, Bollens R, et al. Trans-obturator vaginal tape (TOT) for female stress incontinence: one year follow-up in 120 patients. Eur Urol 2005;48:805–9
   PubMed Web of Science ®Google Scholar
• Waltregny D, Gaspar Y, Reul O. TVT-O for the treatment of female stress urinary incontinence: results of a prospective study after a 3-year minimum follow-up. Eur Urol 2008;53:401–8
   PubMed Web of Science ®Google Scholar
• Abdel-Fattah M, Mostafa A, Familusi A, et al. Prospective randomised controlled trial of transobturator tapes in management of urodynamic stress incontinence in women: 3 year outcomes from the evaluation of transobturator tapes study. Eur Urol 2012;62:843–51
   PubMed Web of Science ®Google Scholar
• Athanasiou S, Grigoriadis T, Zacharakis D, Skampardonis N, Lourantou D, Antsaklis A. Seven years of objective and subjective outcomes of transobturator (TVT-O) vaginal tape: Why do tapes fail? Int Urogynecol J 2014;25:219–25
   Web of Science ®Google Scholar
• Latthe PM, Singh P, Foon R, Toozs-Hobson P. Two routes of transobturator tape procedures in stress urinary incontinence: a meta-analysis with direct and indirect comparison of randomized trials. BJU Int 2010;106:68–76
   PubMed Web of Science ®Google Scholar
• Deng DY, Rutman M, Raz S, Rodriguez LV. Presentation and management of major complications of midurethral slings: are complications under-reported? Neurourol Urodynam 2007; 26:46–52
   PubMed Web of Science ®Google Scholar
• Waltregny D, de Leval J. The TVT-obturator surgical procedure for the treatment of female stress urinary incontinence: a clinical update. Int Urogynecol J 2009;20:337–48
   PubMed Web of Science ®Google Scholar
• David-Montefiore E, Frobert JL, Grisard-Anaf M, et al. Peri-operative complications and pain after the suburethral sling procedure for urinary stress incontinence: a French prospective randomised multicenter study comparing the retropubic and transobturator routes. Eur Urol 2006;49:133–8
   PubMed Web of Science ®Google Scholar
• Bianchi-Ferraro AM, Jarmy-Di Bella ZI, Castro Rde A, et al. Single-incision sling compared with transobturator sling for treating stress urinary incontinence: a randomized controlled trial. Int Urogynecol J 2013;24:1459–65
   Web of Science ®Google Scholar
• Djehdian LM, Araujo MP, Takano CC, et al. Transobturator sling compared with single-incision mini-sling for the treatment of stress urinary incontinence: a randomized controlled trial. Obstet Gynecol 2014;123:553–61
   PubMed Web of Science ®Google Scholar
• Mostafa A, Lim CP, Hopper L, Madhuvrata P, Abdel-Fattah M. Single-incision mini-slings versus standard midurethral slings in surgical management of female stress urinary incontinence: an updated systematic review and meta-analysis of effectiveness and complications. Eur Urol 2014;65:402–27
   PubMed Web of Science ®Google Scholar
• Reynolds WS, Dmochowski RR. Urethral bulking: a urology perspective. Urol Clin North Am 2012;39:279–87
   PubMed Web of Science ®Google Scholar
• Kirchin V, Page T, Keegan PE, et al. Urethral injection therapy for urinary incontinence in women. Cochrane Database of Systematic Reviews 2012. Cochrane Library, Issue 4. Art. No. CD003881
   Google Scholar
• Ghoniem GM, Miller CJ. A systematic review and meta-analysis of Macroplastique for treating female stress urinary incontinence. Int Urogynecol J 2013;24:27–36
   PubMed Web of Science ®Google Scholar
• Kirchin V, Page T, Keegan PE, Atiemo K, Cody JD, McClinton S. Urethral injection therapy for urinary incontinence in women. Cochrane Database of Systematic Reviews. Cochrane Library, Issue 7. Art. No. CD003881
   Google Scholar